Changes in STAT3 signaling can cause the upregulation of cancer-driving oncogenes, such as c-MYC and VEGF, or the downregulation or a silencing of tumor-suppressor genes including PTEN, p53 and PTPN6 [3,29], resulting in signaling favorable to tumor development and progression. The gene discussed is TP53; the disease is neoplasm.